High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Scanu, Anna ^a   Oliviero, Francesca ^a   Gruaz, Lyssia ^b   Sfriso, Paolo ^a   Pozzuoli, Assunta ^a   Frezzato, Federica ^a   Agostini, Carlo ^a   Burger, Danielle ^b   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; URATE; CCL2 PROTEIN, HUMAN; URIC ACID;

ARTICLE; CHEMOTAXIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM VESICLE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FIBROBLAST; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; INHIBITION KINETICS; ISOLATION PROCEDURE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SYNOVIOCYTE; SYNOVIUM; BIOSYNTHESIS; CELL CULTURE; CRYSTALLIZATION; CYTOLOGY; DRUG EFFECT; GOUT; METABOLISM;

CELLS, CULTURED; CHEMOKINE CCL2; CRYSTALLIZATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GOUT; HUMANS; LIPOPROTEINS, HDL; MICROSCOPY, CONFOCAL; SYNOVIAL MEMBRANE; URIC ACID;

EID: 77949483766     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2930     Document Type: Article

References (40)

1. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997, 100:2552-2561. 10.1172/JCI119798, 508456, 9366570.
2. Rollins BJ. MCP-1, MCP-2, MCP-3, MCP-4, and MCP-5. Cytokine Reference 2000, 1145-1160. London: Academic Press, Oppenheim JJ, Feldmann M.
3. Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, Sturk A, Tak PP. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther 2005, 7:R536-R544. 10.1186/ar1706, 1174949, 15899040.
4. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008, 117:1649-1657. 10.1161/CIRCULATIONAHA.107.745091, 18347211.
5. Kusano KF, Nakamura K, Kusano H, Nishii N, Banba K, Ikeda T, Hashimoto K, Yamamoto M, Fujio H, Miura A, Ohta K, Morita H, Saito H, Emori T, Nakamura Y, Kusano I, Ohe T. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J 2004, 68:671-676. 10.1253/circj.68.671, 15226634.
6. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996, 157:4602-4608.
7. Matsukawa A, Miyazaki S, Maeda T, Tanase S, Feng L, Ohkawara S, Yoshinaga M, Yoshimura T. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest 1998, 78:973-985.
8. Villiger PM, Terkeltaub R, Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 1992, 90:488-496. 10.1172/JCI115885, 443125, 1365641.
9. Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992, 149:722-727.
10. So A. Developments in the scientific and clinical understanding of gout. Arthritis Res Ther 2008, 10:221.
11. Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 2009, 60:281-289. 10.1002/art.24185, 19116939.
12. Ortiz-Bravo E, Sieck MS, Schumacher HR. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993, 36:1274-1285. 10.1002/art.1780360912, 8216421.
13. Ryckman C, McColl SR, Vandal K, de Médicis R, Lussier A, Poubelle PE, Tessier PA. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003, 48:2310-2320. 10.1002/art.11079, 12905486.
14. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993, 69:83-91. 10.1006/clin.1993.1153, 8403545.
15. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241. 10.1038/nature04516, 16407889.
16. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28. 10.1186/ar2143, 1906806, 17352828.
17. Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, Li T, Lowell CA, Ling CC, Amrein MW, Shi Y. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008, 29:807-818. 10.1016/j.immuni.2008.09.013, 2642965, 18993083.
18. Terkeltaub RA. What stops a gouty attack?. J Rheumatol 1992, 19:8-10.
19. Terkeltaub R, Martin J, Curtiss LK, Ginsberg MH. Apolipoprotein B mediates the capacity of low density lipoprotein to suppress neutrophil stimulation by particulates. J Biol Chem 1986, 261:15662-15667.
20. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991, 87:20-26. 10.1172/JCI114971, 294981, 1985096.
21. Burt HM, Jackson JK, Rowell J. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. J Rheumatol 1989, 16:809-817.
22. Kumagai Y, Watanabe W, Kobayashi A, Sato K, Onuma S, Sakamoto H. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals. J Rheumatol 2001, 28:2674-2680.
23. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK, Roux-Lombard P, Burger D. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001, 97:2381-2389. 10.1182/blood.V97.8.2381, 11290601.
24. Scanu A, Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol 2008, 83:921-927. 10.1189/jlb.0807551, 18223103.
25. Kanellis J, Watanabe S, Li H, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293. 10.1161/01.HYP.0000072820.07472.3B, 12743010.
26. Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 2003, 18:664-669. 10.1093/ndt/gfg140, 12637633.
27. Scanu A, Oliviero F, Braghetto L, Ramonda R, Luisetto R, Calabrese F, Pozzuoli A, Punzi L. Synoviocyte cultures from synovial fluid. Reumatismo 2007, 59:66-70.
28. Denko CW, Whitehouse MW. Experimental inflammation induced by natural occurring microcrystalline calcium salts. J Rheumatol 1976, 3:54-62.
29. Burger D, Chicheportiche R, Giri JG, Dayer JM. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 1995, 96:38-41. 10.1172/JCI118045, 185170, 7615809.
30. Oynebraten I, Barois N, Hagelsteen K, Johansen FE, Bakke O, Haraldsen G. Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J Immunol 2005, 175:5358-5369.
31. Oynebraten I, Bakke O, Brandtzaeg P, Johansen FE, Haraldsen G. Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood 2004, 104:314-320. 10.1182/blood-2003-08-2891, 15044249.
32. Zupancic G, Ogden D, Magnus CJ, Wheeler-Jones C, Carter TD. Differential exocytosis from human endothelial cells evoked by high intracellular Ca(2+) concentration. J Physiol 2002, 544:741-755. 10.1113/jphysiol.2002.027490, 2290628, 12411520.
33. Schiltz C, Lioté F, Prudhommeaux F, Meunier A, Champy R, Callebert J, Bardin T. Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis Rheum 2002, 46:1643-1650. 10.1002/art.10326, 12115197.
34. Navab M, Reddy S, Van Lenten BJ, Anantharamaiah GM, Fogelman AM. Role of dysfunctional HDL in atherosclerosis. J Lipid Res 2009, 50(Suppl):S145-S149. 10.1194/jlr.R800036-JLR200, 18955731.
35. Shao B, Heinecke JW. HDL, lipid peroxidation, and atherosclerosis. J Lipid Res 2009, 50:599-601. 10.1194/jlr.E900001-JLR200, 19141435.
36. Burger D, Dayer JM, Molnarfi N. Cell contact dependence of inflammatory events. Contemporary Targeted Therapies in Rheumatology 2007, 85-103. Abingdon, UK: Taylor & Francis Books Ltd, Smolen JS, Lipsky PE.
37. Cettour-Rose P, Nguyen TX, Serrander L, Kaufmann MT, Dayer JM, Burger D, Roux-Lombard P. T cell contact-mediated activation of respiratory burst in human polymorphonuclear leukocytes is inhibited by high-density lipoproteins and involves CD18. J Leukoc Biol 2005, 77:52-58.
38. Oliviero F, Sfriso P, Baldo G, Dayer JM, Giunco S, Scanu A, Bernardi D, Ramonda R, Plebani M, Punzi L. Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Clin Exp Rheumatol 2009, 27:79-83.
39. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004, 21:210-221. 10.1097/01.shk.0000111661.09279.82, 14770033.
40. Liu-Bryan R, Lioté F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint Bone Spine 2005, 72:295-302. 10.1016/j.jbspin.2004.12.010, 15990350.